The Scientific Advisory Team at Evgen Pharma provides expert guidance on the research and development of the company's lead product, SFX-01, focusing on its efficacy and safety for treating cancer and neurological conditions. This team advises on clinical trial design, interprets scientific data, and helps navigate regulatory requirements to advance the drug through various stages of clinical development.
View all